The stock of Hepatitis C medicine is sufficient for up to 8 months and will be regularly distributed to patients. The stock of Hepatitis C medicine is sufficient for up to 8 months and will be regularly distributed to patients.

Hepatitis C medicine stocks sufficient for 8 months: Health Spox.

Wed, May. 1, 2019
CAIRO – 1 May 2019: Spokesman for the Ministry of Health Khaled Mujahid stated Tuesday that the stock of Hepatitis C medicine is sufficient for up to 8 months and will be regularly distributed to patients.

He also said that the country is continuing its war against Hepatitis C and that 100 Million Health campaign has achieved its goals to protect Egyptians from non-communicable diseases.

Mujahid explained that Egypt has a pioneering experience in the treatment of Hepatitis C and the provision of medicines praised by world health organizations.

The campaign was launched by President Abdel Fatah al-Sisi under the title "100 Million Health" to eradicate Hepatitis C Virus (HCV) and chronic diseases.

The Health Ministry has vowed to completely eliminate the disease from Egypt by 2022.
The spokesperson of the Ministry of Health told Egypt Today that the three-phase campaign started in October 2018 and will end in April 2019.

In Jan., the minister of health unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries that have an estimated 3.7 million hepatitis C patients, representing 30 percent of the total number of infected people in Africa.
 
There are no comments on this article.

Leave a comment